
Cancer Weekly (12.10.02) - Friday, December 20, 2002
Patrick S. Moore and Yuan Chang - the team that previously discovered KSHV - examined the expression of a virus-derived cytokine (a hormone-like substance that regulates cells during an immune response) in KSHV. Moore and Chang found that this cytokine, virus-derived interleukin-6 (vIL-6), not only inhibits immune function but also causes cancerous cells to grow. vIL-6 protects virus-infected cells from undergoing growth arrest and apoptosis, or cell death, which is the normal way that the immune system attempts to limit viral infections. The full report, "Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity," was published recently in Science (2002;298(5597):1432-1435).
vIL-6 inhibits the signaling of antiviral factor interferon (IFN), a normal immune response that blocks virus-infected cells from growing. However, KSHV has a built-in sensor mechanism that perceives an increased signaling of IFN and responds by increasing the production of vIL-6, in effect inhibiting the activation of the tumor-suppressor pathway during the immune response and acting like a switch by turning off the production of IFN. In addition, in some cells, vIL-6 not only stops the suppression of tumors, but also causes normal cells that are not infected with KSHV to proliferate abnormally.
"These results illustrate that tumor viruses can cause cancers because they have evolved to subvert cell defenses and make use of the same signaling pathways that are used to suppress tumors to instead cause tumors to grow," said Chang. "In other words, the virus is able to sense its environment and modify that environment to make it more habitable for the virus. By inhibiting a normal immune mechanism to evade the immune system, the virus can accidentally trigger tumor cell growth." Moore and Chang cautioned that this mechanism does not entirely explain how KSHV causes cancer, but it is an important principle in understanding tumor virology. Chang said vIL-6 may be a promising target for novel therapies against KSHV-associated tumors often found in lymphoma and Castleman disease, a rare disorder characterized by noncancerous tumors that may develop in the lymph node tissue throughout the body.
021220
AD022470
Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.